Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSRT Combined With Temozolomide for Refractory Brain Metastases
NCT02654106Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in brain metastases, sponsored by Chinese Academy of Medical Sciences. Started Oct 2011; status: completed.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT02654106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654106.